439555-96-1

Basic information

• Product Name: HUMAN TARC
• Synonyms: TARC, HUMAN;THYMUS AND ACTIVATION-REGULATED CHEMOKINE (HUMAN);RECOMBINANT HUMAN TARC;H-ALA-ARG-GLY-THR-ASN-VAL-GLY-ARG-GLU-CYS-CYS-LEU-GLU-TYR-PHE-LYS-GLY-ALA-ILE-PRO-LEU-ARG-LYS-LEU-LYS-THR-TRP-TYR-GLN-THR-SER-GLU-ASP-CYS-SER-ARG-ASP-ALA-ILE-VAL-PHE-VAL-THR-VAL-GLN-GLY-ARG-ALA-ILE-CYS-SER-ASP-PRO-ASN-ASN-LYS-ARG-VAL-LYS-ASN-ALA-VAL-LYS-TYR-LEU-GLN-SER-LEU-GLU-ARG-SER-OH;HUMAN TARC;HUMAN TARC (CCL17);HUMAN TARC (CCL17) CHEMICALLY SYNTHESIZED CHEMOKINE;HUMAN THYMUS ACTIVATION REGULATION CHEMOKINE
• CAS NO: 439555-96-1
• Molecular Weight: 8079.27
• Mol File: 439555-96-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: HUMAN TARC(CAS DataBase Reference)
• NIST Chemistry Reference: HUMAN TARC(439555-96-1)
• EPA Substance Registry System: HUMAN TARC(439555-96-1)

Safety Data

• Hazardous Substances Data: 439555-96-1(Hazardous Substances Data)

Usage

General Description

HUMAN TARC, also known as C-C chemokine receptor type 7 (CCR7), is a protein that is involved in the immune system and plays a role in regulating the migration of white blood cells. It is a chemokine receptor that is expressed on the surface of T-cells and dendritic cells, and is known to be involved in the lymphocyte homing to secondary lymphoid tissues. HUMAN TARC has been found to be associated with various diseases, including cancer, autoimmune disorders, and inflammatory conditions. Studies have shown that targeting HUMAN TARC may have therapeutic potential in the treatment of these diseases by modulating the immune response and reducing inflammation. Further research into the function and regulation of HUMAN TARC may lead to the development of novel treatments for these conditions.